Slide Presentations: Sunday, October 23, 2011 |

The Effect of ATS/IDSA Antibiotic Guidelines on Clinical Outcomes in Hemodialysis Patients With Pneumonia FREE TO VIEW

Stephanie Pezzo, MD; Brice Taylor, MD; David Solomon, MD
Chest. 2011;140(4_MeetingAbstracts):900A. doi:10.1378/chest.1120054
Text Size: A A A
Published online


PURPOSE: Although the 2005 American Thoracic Society (ATS)/Infectious Disease Society of American (IDSA) antibiotic guidelines included pneumonia occurring in patients receiving chronic hemodialysis (HD) in the category of healthcare-associated pneumonia (HCAP), little data exists to support this classification. This study compares clinical outcomes in HD patients hospitalized with pneumonia who are treated according to the 2005 ATS/IDSA guidelines versus those treated according to guidelines recommending community-acquired antibiotic coverage.

METHODS: We retrospectively identified 300 patients admitted with the diagnosis of pneumonia and end-stage renal disease requiring hemodialysis. Patients were categorized into the community-acquired pneumonia (CAP) therapy group or the HCAP therapy group based on the antibiotic regimen they received. An intention-to-treat analysis was used to compare time-to-oral-therapy, length-of-stay, and mortality. A multivariate survival model using propensity analysis was used to adjust for variability within groups.

RESULTS: Data analysis suggest that, in our study population, pneumonia treated with CAP therapy will have comparable mortality to patients treated with HCAP therapy, and a decreased time-to-oral-therapy and length-of-stay.

CONCLUSIONS: Our data suggest that treating pneumonia in HD patients with CAP therapy may not be only safe but advantageous compared to broad spectrum multi-agent therapy as currently recomended by the IDSA/ATS guidelines.

CLINICAL IMPLICATIONS: Recognizing the inherent limitations of a small, retrospective study, our results call for further scientific evidence clarifying the role of chronic HD as a risk factor for multidrug resistant pneumonia.

DISCLOSURE: The following authors have nothing to disclose: Stephanie Pezzo, Brice Taylor, David Solomon

No Product/Research Disclosure Information

10:45 AM - 12:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543